scholarly article | Q13442814 |
P50 | author | Michal Brylinski | Q59698544 |
Jeffrey Mitchell Lemoine | Q61659112 | ||
Rajiv Gandhi Govindaraj | Q48344460 | ||
P2093 | author name string | Misagh Naderi | |
P2860 | cites work | DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 |
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling | Q24293500 | ||
Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization | Q24626539 | ||
Improving protein fold recognition and template-based modeling by employing probabilistic-based matching between predicted one-dimensional structural properties of query and corresponding native properties of templates | Q24632911 | ||
N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease | Q26825619 | ||
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor | Q27618507 | ||
SPOT-Ligand: Fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity | Q58041489 | ||
ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand | Q27684920 | ||
Protein secondary structure prediction based on position-specific scoring matrices | Q27860483 | ||
JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities | Q28082598 | ||
Processing and analysis of CASP3 protein structure predictions | Q28145979 | ||
A knowledge-based energy function for protein-ligand, protein-protein, and protein-DNA complexes | Q28242753 | ||
Assignment of the human PTK6 gene encoding a non-receptor protein tyrosine kinase to 20q13.3 by fluorescence in situ hybridization | Q28248006 | ||
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment | Q28256122 | ||
Structure and chemical inhibition of the RET tyrosine kinase domain | Q28259608 | ||
eMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein models | Q28543048 | ||
Comparison of the predicted and observed secondary structure of T4 phage lysozyme | Q29398301 | ||
Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
Scoring function for automated assessment of protein structure template quality | Q29615862 | ||
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery | Q29615875 | ||
The Protein Data Bank | Q29616068 | ||
Automated analysis of interatomic contacts in proteins | Q29616410 | ||
Protein structure modeling with MODELLER. | Q30359504 | ||
PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity. | Q30377334 | ||
Protein single-model quality assessment by feature-based probability density functions. | Q30386412 | ||
Build-Up Algorithm for Atomic Correspondence between Chemical Structures | Q30404556 | ||
eThread: a highly optimized machine learning-based approach to meta-threading and the modeling of protein tertiary structures | Q30424100 | ||
Fr-TM-align: a new protein structural alignment method based on fragment alignments and the TM-score | Q33392469 | ||
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. | Q34401845 | ||
A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation | Q34731493 | ||
Protein threading using context-specific alignment potential | Q36960683 | ||
Rare diseases research: expanding collaborative translational research opportunities | Q36999192 | ||
Incentives for orphan drug research and development in the United States | Q37074235 | ||
UniProt: the universal protein knowledgebase | Q37556842 | ||
Drug repositioning for orphan diseases | Q37866927 | ||
Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions | Q38620756 | ||
Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution. | Q39086848 | ||
eFindSite: Enhanced Fingerprint-Based Virtual Screening Against Predicted Ligand Binding Sites in Protein Models | Q39531365 | ||
Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning. | Q40464569 | ||
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. | Q44106085 | ||
Memantine hydrochloride. | Q44811878 | ||
eFindSite: Improved prediction of ligand binding sites in protein models using meta-threading, machine learning and auxiliary ligands | Q45958946 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | orphan disease | Q15712664 |
P577 | publication date | 2017-12-10 | |
P1433 | published in | Journal of Molecular Biology | Q925779 |
P1476 | title | eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs |
Q62494154 | Binding site matching in rational drug design: algorithms and applications |
Q51556901 | Comparative assessment of strategies to identify similar ligand-binding pockets in proteins |
Q61658708 | DeepDrug3D: Classification of ligand-binding pockets in proteins with a convolutional neural network |
Q51556600 | Large-scale computational drug repositioning to find treatments for rare diseases |
Q57001273 | eModel-BDB: a database of comparative structure models of drug-target interactions from the Binding Database |
Search more.